HLB Life Science Co Ltd
KOSDAQ:067630
HLB Life Science Co Ltd
Revenue
HLB Life Science Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
H
|
HLB Life Science Co Ltd
KOSDAQ:067630
|
Revenue
₩90.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
15%
|
C
|
Chorokbaem Healthcare Co Ltd
KRX:118000
|
Revenue
₩55.8B
|
CAGR 3-Years
28%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
Revenue
₩2.1T
|
CAGR 3-Years
15%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
W
|
WSI Co Ltd
KOSDAQ:299170
|
Revenue
₩27.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
W
|
Wonik Co Ltd
KOSDAQ:032940
|
Revenue
₩129.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
See Also
What is HLB Life Science Co Ltd's Revenue?
Revenue
90.7B
KRW
Based on the financial report for Mar 31, 2024, HLB Life Science Co Ltd's Revenue amounts to 90.7B KRW.
What is HLB Life Science Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
15%
Over the last year, the Revenue growth was -21%. The average annual Revenue growth rates for HLB Life Science Co Ltd have been 9% over the past three years , -3% over the past five years , and 15% over the past ten years .